Global Transfection Technologies Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201110200 | Category: Service & Software | Pages: 121 | Format: PDF | Published Date: July 29,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Transfection Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Transfection Technologies market size is estimated to be worth US$ 769.1 million in 2021 and is forecast to a readjusted size of USD 1191.2 million by 2028 with a CAGR of 6.5% during review period. Research Centers & Academic/Government Institutes accounting for  % of the Transfection Technologies global market in 2021, is projected to value USD   million by 2028, growing at a  % CAGR in next six years. While Lipofection segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Transfection Technologies include Bio-Rad, Polyplus Transfection, MaxCyte, Promega Corporation, and Thermo Fisher Scientific, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Transfection Technologies market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Lipofection
    Electroporation
    Nucleofection
    Others
Market segment by Application, can be divided into
    Research Centers & Academic/Government Institutes
    Hospitals & Clinics
    Pharmaceutical & Biotechnology Companies
    Others
Market segment by players, this report covers
    Bio-Rad
    Polyplus Transfection
    MaxCyte
    Promega Corporation
    Thermo Fisher Scientific
    Affymetrix
    Agilent Technologies
    Altogen Biosystems
    Boca Scientific
    Chemicell
    CytoPulse
    Clontech
    Deliverics
    GE Healthcare Life Sciences
    IBA GmbH
    Lonza
    Inovio Pharmaceuticals
    Merck KGaA
    Miltenyi Biotec
    Oz Biosciences
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Transfection Technologies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Transfection Technologies, with revenue, gross margin and global market share of Transfection Technologies from 2019 to 2022.
Chapter 3, the Transfection Technologies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Transfection Technologies market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Transfection Technologies research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Transfection Technologies
    1.2 Classification of Transfection Technologies by Type
        1.2.1 Overview: Global Transfection Technologies Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Transfection Technologies Revenue Market Share by Type in 2021
        1.2.3 Lipofection
        1.2.4 Electroporation
        1.2.5 Nucleofection
        1.2.6 Others
    1.3 Global Transfection Technologies Market by Application
        1.3.1 Overview: Global Transfection Technologies Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Research Centers & Academic/Government Institutes
        1.3.3 Hospitals & Clinics
        1.3.4 Pharmaceutical & Biotechnology Companies
        1.3.5 Others
    1.4 Global Transfection Technologies Market Size & Forecast
    1.5 Global Transfection Technologies Market Size and Forecast by Region
        1.5.1 Global Transfection Technologies Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Transfection Technologies Market Size by Region, (2017-2022)
        1.5.3 North America Transfection Technologies Market Size and Prospect (2017-2028)
        1.5.4 Europe Transfection Technologies Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Transfection Technologies Market Size and Prospect (2017-2028)
        1.5.6 South America Transfection Technologies Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Transfection Technologies Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Transfection Technologies Market Drivers
        1.6.2 Transfection Technologies Market Restraints
        1.6.3 Transfection Technologies Trends Analysis
2 Company Profiles
    2.1 Bio-Rad
        2.1.1 Bio-Rad Details
        2.1.2 Bio-Rad Major Business
        2.1.3 Bio-Rad Transfection Technologies Product and Solutions
        2.1.4 Bio-Rad Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Bio-Rad Recent Developments and Future Plans
    2.2 Polyplus Transfection
        2.2.1 Polyplus Transfection Details
        2.2.2 Polyplus Transfection Major Business
        2.2.3 Polyplus Transfection Transfection Technologies Product and Solutions
        2.2.4 Polyplus Transfection Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Polyplus Transfection Recent Developments and Future Plans
    2.3 MaxCyte
        2.3.1 MaxCyte Details
        2.3.2 MaxCyte Major Business
        2.3.3 MaxCyte Transfection Technologies Product and Solutions
        2.3.4 MaxCyte Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 MaxCyte Recent Developments and Future Plans
    2.4 Promega Corporation
        2.4.1 Promega Corporation Details
        2.4.2 Promega Corporation Major Business
        2.4.3 Promega Corporation Transfection Technologies Product and Solutions
        2.4.4 Promega Corporation Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Promega Corporation Recent Developments and Future Plans
    2.5 Thermo Fisher Scientific
        2.5.1 Thermo Fisher Scientific Details
        2.5.2 Thermo Fisher Scientific Major Business
        2.5.3 Thermo Fisher Scientific Transfection Technologies Product and Solutions
        2.5.4 Thermo Fisher Scientific Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
    2.6 Affymetrix
        2.6.1 Affymetrix Details
        2.6.2 Affymetrix Major Business
        2.6.3 Affymetrix Transfection Technologies Product and Solutions
        2.6.4 Affymetrix Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Affymetrix Recent Developments and Future Plans
    2.7 Agilent Technologies
        2.7.1 Agilent Technologies Details
        2.7.2 Agilent Technologies Major Business
        2.7.3 Agilent Technologies Transfection Technologies Product and Solutions
        2.7.4 Agilent Technologies Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Agilent Technologies Recent Developments and Future Plans
    2.8 Altogen Biosystems
        2.8.1 Altogen Biosystems Details
        2.8.2 Altogen Biosystems Major Business
        2.8.3 Altogen Biosystems Transfection Technologies Product and Solutions
        2.8.4 Altogen Biosystems Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Altogen Biosystems Recent Developments and Future Plans
    2.9 Boca Scientific
        2.9.1 Boca Scientific Details
        2.9.2 Boca Scientific Major Business
        2.9.3 Boca Scientific Transfection Technologies Product and Solutions
        2.9.4 Boca Scientific Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Boca Scientific Recent Developments and Future Plans
    2.10 Chemicell 
        2.10.1 Chemicell Details
        2.10.2 Chemicell Major Business
        2.10.3 Chemicell Transfection Technologies Product and Solutions
        2.10.4 Chemicell Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Chemicell Recent Developments and Future Plans
    2.11 CytoPulse
        2.11.1 CytoPulse Details
        2.11.2 CytoPulse Major Business
        2.11.3 CytoPulse Transfection Technologies Product and Solutions
        2.11.4 CytoPulse Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 CytoPulse Recent Developments and Future Plans
    2.12 Clontech
        2.12.1 Clontech Details
        2.12.2 Clontech Major Business
        2.12.3 Clontech Transfection Technologies Product and Solutions
        2.12.4 Clontech Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Clontech Recent Developments and Future Plans
    2.13 Deliverics
        2.13.1 Deliverics Details
        2.13.2 Deliverics Major Business
        2.13.3 Deliverics Transfection Technologies Product and Solutions
        2.13.4 Deliverics Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Deliverics Recent Developments and Future Plans
    2.14 GE Healthcare Life Sciences
        2.14.1 GE Healthcare Life Sciences Details
        2.14.2 GE Healthcare Life Sciences Major Business
        2.14.3 GE Healthcare Life Sciences Transfection Technologies Product and Solutions
        2.14.4 GE Healthcare Life Sciences Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 GE Healthcare Life Sciences Recent Developments and Future Plans
    2.15 IBA GmbH
        2.15.1 IBA GmbH Details
        2.15.2 IBA GmbH Major Business
        2.15.3 IBA GmbH Transfection Technologies Product and Solutions
        2.15.4 IBA GmbH Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 IBA GmbH Recent Developments and Future Plans
    2.16 Lonza
        2.16.1 Lonza Details
        2.16.2 Lonza Major Business
        2.16.3 Lonza Transfection Technologies Product and Solutions
        2.16.4 Lonza Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Lonza Recent Developments and Future Plans
    2.17 Inovio Pharmaceuticals
        2.17.1 Inovio Pharmaceuticals Details
        2.17.2 Inovio Pharmaceuticals Major Business
        2.17.3 Inovio Pharmaceuticals Transfection Technologies Product and Solutions
        2.17.4 Inovio Pharmaceuticals Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.17.5 Inovio Pharmaceuticals Recent Developments and Future Plans
    2.18 Merck KGaA
        2.18.1 Merck KGaA Details
        2.18.2 Merck KGaA Major Business
        2.18.3 Merck KGaA Transfection Technologies Product and Solutions
        2.18.4 Merck KGaA Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.18.5 Merck KGaA Recent Developments and Future Plans
    2.19 Miltenyi Biotec
        2.19.1 Miltenyi Biotec Details
        2.19.2 Miltenyi Biotec Major Business
        2.19.3 Miltenyi Biotec Transfection Technologies Product and Solutions
        2.19.4 Miltenyi Biotec Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.19.5 Miltenyi Biotec Recent Developments and Future Plans
    2.20 Oz Biosciences
        2.20.1 Oz Biosciences Details
        2.20.2 Oz Biosciences Major Business
        2.20.3 Oz Biosciences Transfection Technologies Product and Solutions
        2.20.4 Oz Biosciences Transfection Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.20.5 Oz Biosciences Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Transfection Technologies Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Transfection Technologies Players Market Share in 2021
        3.2.2 Top 10 Transfection Technologies Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Transfection Technologies Players Head Office, Products and Services Provided
    3.4 Transfection Technologies Mergers & Acquisitions
    3.5 Transfection Technologies New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Transfection Technologies Revenue and Market Share by Type (2017-2022)
    4.2 Global Transfection Technologies Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Transfection Technologies Revenue Market Share by Application (2017-2022)
    5.2 Global Transfection Technologies Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Transfection Technologies Revenue by Type (2017-2028)
    6.2 North America Transfection Technologies Revenue by Application (2017-2028)
    6.3 North America Transfection Technologies Market Size by Country
        6.3.1 North America Transfection Technologies Revenue by Country (2017-2028)
        6.3.2 United States Transfection Technologies Market Size and Forecast (2017-2028)
        6.3.3 Canada Transfection Technologies Market Size and Forecast (2017-2028)
        6.3.4 Mexico Transfection Technologies Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Transfection Technologies Revenue by Type (2017-2028)
    7.2 Europe Transfection Technologies Revenue by Application (2017-2028)
    7.3 Europe Transfection Technologies Market Size by Country
        7.3.1 Europe Transfection Technologies Revenue by Country (2017-2028)
        7.3.2 Germany Transfection Technologies Market Size and Forecast (2017-2028)
        7.3.3 France Transfection Technologies Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Transfection Technologies Market Size and Forecast (2017-2028)
        7.3.5 Russia Transfection Technologies Market Size and Forecast (2017-2028)
        7.3.6 Italy Transfection Technologies Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Transfection Technologies Revenue by Type (2017-2028)
    8.2 Asia-Pacific Transfection Technologies Revenue by Application (2017-2028)
    8.3 Asia-Pacific Transfection Technologies Market Size by Region
        8.3.1 Asia-Pacific Transfection Technologies Revenue by Region (2017-2028)
        8.3.2 China Transfection Technologies Market Size and Forecast (2017-2028)
        8.3.3 Japan Transfection Technologies Market Size and Forecast (2017-2028)
        8.3.4 South Korea Transfection Technologies Market Size and Forecast (2017-2028)
        8.3.5 India Transfection Technologies Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Transfection Technologies Market Size and Forecast (2017-2028)
        8.3.7 Australia Transfection Technologies Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Transfection Technologies Revenue by Type (2017-2028)
    9.2 South America Transfection Technologies Revenue by Application (2017-2028)
    9.3 South America Transfection Technologies Market Size by Country
        9.3.1 South America Transfection Technologies Revenue by Country (2017-2028)
        9.3.2 Brazil Transfection Technologies Market Size and Forecast (2017-2028)
        9.3.3 Argentina Transfection Technologies Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Transfection Technologies Revenue by Type (2017-2028)
    10.2 Middle East & Africa Transfection Technologies Revenue by Application (2017-2028)
    10.3 Middle East & Africa Transfection Technologies Market Size by Country
        10.3.1 Middle East & Africa Transfection Technologies Revenue by Country (2017-2028)
        10.3.2 Turkey Transfection Technologies Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Transfection Technologies Market Size and Forecast (2017-2028)
        10.3.4 UAE Transfection Technologies Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Transfection Technologies Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?